Literature DB >> 4674512

An experimental model of tardive dyskinesia.

H L Klawans, R Rubovits.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4674512     DOI： 10.1007/bf01245320

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  34 in total

1.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

2.  Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour.

Authors:  R L Fog; A Randrup; H Pakkenberg
Journal:  Psychopharmacologia       Date:  1967

Review 3.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

4.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

5.  Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1969-02       Impact factor: 4.432

6.  Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats.

Authors:  R L Fog; A Randrup; H Pakkenberg
Journal:  Psychopharmacologia       Date:  1968

7.  Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats.

Authors:  R Fog; H Pakkenberg
Journal:  Exp Neurol       Date:  1971-04       Impact factor: 5.330

8.  The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.

Authors:  J M van Rossum
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-04

9.  Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats.

Authors:  A M Ernst; P G Smelik
Journal:  Experientia       Date:  1966-12-15

10.  Effects of chlorpromazine on the metabolism of catecholamines in dog brain.

Authors:  H C Guldberg; C M Yates
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739
View more
  41 in total

Review 1.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole.

Authors:  Ashish Sharma; Sriram Ramaswamy; Vijay K Dewan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up.

Authors:  Rakesh Goyal; Salam Hemabati Devi
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

4.  Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.

Authors:  M E Gnegy; A Lucchelli; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

Review 5.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.

Authors:  R Dunstan; D M Jackson
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

7.  Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.

Authors:  R Dunstan; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

8.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Levodopa and receptor sensitivity modification in tardive dyskinesia.

Authors:  D E Casey; J Gerlach; N Bjørndal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.

Authors:  R D Eibergen; K R Carlson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.